Clinical Trial Update: Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase I trial evaluating cabazitaxel, mitoxantrone, and prednisone in metastatic castration-resistant prostate cancer has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• Mitoxantrone (mitoxantrone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Rahul Aggarwal | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: COMPLETED